Slideshow
Author(s):
Three new studies from Obesity Week 2018 highlight non-surgical weight loss strategies for obese patients.
Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology
Genetic Determinants of LDL-C Inversely Linked to Type 2 Diabetes Risk
Diabetes Dialogue: The Evolving Role of Registered Dietitian Nutritionists in Obesity
FMT Shows Promise for Type 1 Diabetes, Gastroenteropathy Treatment in Pilot Trial
Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint